Larvol Delta - FDA-Grants-Fast-Track-Designation-to-ANPD001-Autologous-Investigational-Cell-Therapy-for-the-Treatment-of-Parkinsons-Disease

ANPD001 - Aspen Neurosci

https://www.prnewswire.com/news-releases/fda-grants-fast-track-designation-to-anpd001-autologous-investigational-cell-therapy-for-the-treatment-of-parkinsons-disease-301961828.html

Oct 19, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next